Smoking and gastric sleeve surgery are fundamentally incompatible in the pre-operative period, and understanding why is essential for anyone considering this procedure. Sleeve gastrectomy carries inherent surgical risks that are significantly amplified by tobacco use — from impaired wound healing and staple-line leaks to serious respiratory and cardiovascular complications. UK bariatric programmes, guided by NICE, the Royal College of Surgeons of England, and BOMSS, routinely require confirmed smoking cessation before listing patients for surgery. This article explains how smoking affects your eligibility, what the NHS guidelines say, the specific health risks involved, and how to access free support to quit.

Why Smoking Affects Your Eligibility for Gastric Sleeve Surgery

Active smoking is typically a reason to defer gastric sleeve surgery in UK bariatric programmes because nicotine and carbon monoxide impair wound healing, increase staple-line leak risk, and raise anaesthetic and respiratory complication rates.

Have any more questions about this? Message our pharmaceutical team to get more info →

Smoking is one of the most significant modifiable risk factors assessed during the pre-operative evaluation for gastric sleeve surgery (sleeve gastrectomy). Bariatric surgical teams across the UK routinely screen patients for tobacco use because smoking directly impairs the body's ability to heal, increases anaesthetic risk, and raises the likelihood of serious post-operative complications. For many NHS and private bariatric programmes, active smoking is treated as a reason to defer elective weight-loss surgery until cessation has been achieved and verified, though specific policies vary between centres.

The reasons are both physiological and practical. Nicotine causes vasoconstriction — narrowing of blood vessels — which reduces oxygen delivery to healing tissues. Carbon monoxide from cigarette smoke binds to haemoglobin, further limiting the blood's oxygen-carrying capacity. Together, these effects significantly impair wound healing and increase the risk of staple-line (gastric) leaks, staple-line complications, and infection — all of which are particularly serious following gastric sleeve surgery. Published evidence, including data from major bariatric surgery registries, confirms that smokers undergoing sleeve gastrectomy face a meaningfully higher rate of these complications compared with non-smokers.

Beyond surgical risk, smoking is associated with a higher incidence of post-operative gastro-oesophageal reflux disease (GORD), which is already a known concern after sleeve gastrectomy. Patients who smoke are also statistically more likely to experience respiratory complications under general anaesthesia, including chest infections and a prolonged requirement for postoperative ventilation or critical care. For these reasons, most bariatric centres will require documented evidence of smoking cessation — often confirmed via an exhaled carbon monoxide breath test — before listing a patient for surgery. The Royal College of Anaesthetists' Fitter Better Sooner guidance and the Royal College of Surgeons of England both highlight the importance of stopping smoking before any elective operation to reduce anaesthetic and surgical risk.

NHS and NICE Guidelines on Smoking Before Bariatric Surgery

NICE NG125 recommends patients stop smoking before elective surgery and are referred to stop smoking services; the Royal College of Surgeons and Royal College of Anaesthetists advise a minimum of eight weeks' cessation before any elective operation.

NICE guidance on obesity (CG189) and perioperative care (NG125) emphasises that patients being considered for bariatric surgery should be assessed holistically, with lifestyle factors including smoking addressed as part of pre-operative preparation. NICE NG125 specifically recommends that patients are advised to stop smoking before elective surgery and are offered referral to stop smoking services. Whilst NICE does not mandate a single universal minimum cessation period exclusively for bariatric procedures, smoking cessation is strongly supported as part of pre-operative optimisation across all surgical specialties.

The Royal College of Surgeons of England and the Royal College of Anaesthetists recommend that patients ideally stop smoking at least eight weeks before any elective operation. This recommendation is based on evidence that eight weeks of cessation allows meaningful recovery of mucociliary function in the airways, improved wound healing capacity, and a reduction in cardiovascular risk during anaesthesia. Many NHS bariatric units apply this as a minimum requirement; some centres may ask for longer periods of abstinence — patients should check directly with their bariatric team for local policy.

In practice, NHS bariatric multidisciplinary teams (MDTs) — comprising surgeons, dietitians, psychologists, and specialist nurses — will review a patient's smoking status at multiple points during the pre-operative pathway, in line with British Obesity and Metabolic Surgery Society (BOMSS) perioperative guidance. Patients who are found to be actively smoking at the time of their pre-operative assessment may have their surgery postponed. It is important to be transparent with your clinical team, as concealing smoking status not only undermines your safety but may also affect your post-operative outcomes and ongoing care. Your GP can provide referrals to NHS Stop Smoking Services, in line with NICE NG92, as part of your surgical preparation.

Health Risks of Smoking During the Surgical and Recovery Period

Smoking during the peri-operative period significantly raises the risk of staple-line leaks, wound infection, pulmonary complications, DVT, pulmonary embolism, and delayed gastric healing following sleeve gastrectomy.

The peri-operative period — the time immediately surrounding surgery — is when the risks associated with smoking are most acute. Patients who continue to smoke up to the point of their operation face a significantly elevated risk of complications both during and after the procedure. These risks are well-documented in the surgical literature and are particularly relevant to gastric sleeve surgery, which involves permanent alteration of the stomach.

Key risks associated with smoking during the surgical and recovery period include:

• Staple-line (gastric) leaks: Reduced tissue perfusion caused by nicotine impairs healing of the staple line used to create the sleeve, increasing the risk of a potentially life-threatening leak.

• Wound infection: Poor oxygenation of tissues creates an environment more susceptible to bacterial infection at both internal and external wound sites.

• Pulmonary complications: Smokers are at higher risk of post-operative pneumonia, atelectasis (partial lung collapse), and a prolonged recovery from general anaesthesia, as outlined in Royal College of Anaesthetists patient guidance.

• Deep vein thrombosis (DVT) and pulmonary embolism (PE): Smoking has procoagulant and adverse endothelial effects that compound the already elevated thrombotic risk associated with bariatric surgery, as described in NICE NG89 on VTE prophylaxis.

• Delayed gastric healing: The stomach remnant requires adequate blood supply to heal correctly; smoking compromises this process.

Recovery from gastric sleeve surgery typically spans several weeks, during which the body is under considerable physiological stress. Continuing to smoke during this period not only prolongs recovery but may necessitate further medical intervention, including hospitalisation. Even occasional or 'social' smoking during recovery carries meaningful risk and should be avoided entirely.

Important — when to seek urgent help: If at any point during your recovery you experience severe abdominal or chest pain, a rapid heartbeat, high temperature, breathlessness, or persistent vomiting, seek urgent medical attention immediately. Call 999 in an emergency or contact NHS 111 for urgent advice.

How Long You Should Stop Smoking Before Your Operation

Most NHS bariatric programmes require a minimum of eight weeks of confirmed abstinence before gastric sleeve surgery, verified by an exhaled carbon monoxide breath test, though some centres require longer periods.

The question of how long to stop smoking before gastric sleeve surgery is one that patients frequently ask, and the answer depends on both general surgical guidance and the specific policies of your bariatric centre. As a general principle, the longer the period of cessation before surgery, the greater the reduction in operative risk. However, even short periods of abstinence confer measurable benefit.

Aligned with NHS Better Health and WHO evidence on smoking cessation and surgical outcomes, the following timeline illustrates physiological recovery after stopping smoking:

• 12–24 hours: Carbon monoxide levels in the blood normalise, improving oxygen delivery to tissues.

• 2–4 weeks: Circulation begins to improve and lung function starts to recover.

• 6–8 weeks: Wound healing capacity and immune function show significant improvement; respiratory complication risk decreases substantially. This is the minimum period recommended by the Royal College of Surgeons of England and the Royal College of Anaesthetists before elective surgery.

• 3–6 months: Mucociliary clearance in the airways is largely restored; cardiovascular risk continues to decline.

Most NHS bariatric programmes require a minimum of eight weeks of confirmed abstinence before surgery, with confirmation typically provided via an exhaled carbon monoxide breath test at the pre-operative assessment, in line with BOMSS perioperative guidance. Some centres may ask for longer periods — contact your bariatric team directly to understand their specific requirements.

Quitting abruptly is safe for most people; however, success rates are significantly higher with structured support. Beginning the cessation process as early as possible in your bariatric pathway — ideally at the point of referral — gives you the best chance of meeting the required abstinence period and maintaining long-term smoke-free status. Behavioural support combined with pharmacotherapy is the most effective approach, as outlined in NICE NG92.

Support Available to Help You Quit Smoking on the NHS

NHS Stop Smoking Services provide free NRT, varenicline, bupropion, and behavioural support; NICE NG92 confirms that combining pharmacotherapy with behavioural support is the most effective cessation approach.

The NHS offers a comprehensive range of free stop smoking services, and patients preparing for gastric sleeve surgery are strongly encouraged to access these resources as early as possible. Evidence consistently shows — as summarised in NICE NG92 and National Centre for Smoking Cessation and Training (NCSCT) guidance — that using a combination of behavioural support and pharmacotherapy is significantly more effective than attempting to quit without assistance.

NHS Stop Smoking Services are available through your GP surgery, local pharmacies, and dedicated community stop smoking clinics. These services offer:

• Nicotine replacement therapy (NRT): Available in various forms including patches, gum, lozenges, inhalators, and nasal sprays. NRT helps manage cravings and withdrawal symptoms without the harmful effects of tobacco smoke. NRT is suitable for most people, but discuss with your GP or pharmacist if you have any underlying health conditions.

• Varenicline: A prescription medication that reduces cravings and the pleasurable effects of smoking. It is not suitable for everyone — your prescriber will assess whether it is appropriate for you. If you experience any suspected side effects from varenicline or any other stop smoking medicine, report these via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk or via the Yellow Card app).

• Bupropion: Another prescription option that acts on neurotransmitters involved in nicotine dependence. As with varenicline, suitability should be discussed with your prescriber.

• Behavioural support: One-to-one or group counselling sessions that provide strategies for managing triggers and maintaining motivation.

The NHS also provides the free Better Health: Quit Smoking app and online tools, which offer daily support and tracking. Your bariatric team or GP can refer you directly to local services.

Regarding e-cigarettes (vaping): NHS and Office for Health Improvements and Disparities (OHID) evidence indicates that vaping can help people quit smoking and is substantially less harmful than continued tobacco use. However, some bariatric centres may require abstinence from all nicotine-containing products — including e-cigarettes — in the weeks immediately before surgery. Check your local bariatric team's policy before using vaping as a cessation aid in the pre-operative period.

Long-Term Benefits of Staying Smoke-Free After Gastric Sleeve Surgery

Sustained smoking cessation after sleeve gastrectomy reduces the risk of GORD, peptic ulceration, cardiovascular disease, COPD, and multiple cancers, enhancing the long-term metabolic benefits of the procedure.

Achieving and maintaining smoking cessation after gastric sleeve surgery offers substantial long-term health benefits that complement and enhance the outcomes of the procedure itself. Weight-loss surgery is a tool for improving metabolic health, and remaining smoke-free ensures that the gains made through surgery are not undermined by the wide-ranging harms of tobacco use.

From a gastrointestinal perspective, staying smoke-free significantly reduces the risk of developing or worsening GORD — a condition that affects a notable proportion of patients following sleeve gastrectomy. Smoking weakens the lower oesophageal sphincter and increases gastric acid production, both of which exacerbate reflux symptoms. Patients who remain smoke-free are also less likely to develop peptic ulceration, which carries particular risk in the altered anatomy of a sleeved stomach.

Beyond gastrointestinal health, the long-term benefits of sustained cessation include:

• Cardiovascular health: Reduced risk of heart disease, stroke, and hypertension — conditions that are already improved by weight loss following bariatric surgery.

• Respiratory function: Improved lung capacity and reduced risk of chronic obstructive pulmonary disease (COPD).

• Cancer risk reduction: Smoking is a leading cause of multiple cancers; cessation at any age reduces lifetime risk.

• Mental wellbeing: Many former smokers report improved mood, energy levels, and quality of life following sustained cessation.

• Weight management: Some people experience modest weight gain after stopping smoking; however, patients who have undergone bariatric surgery typically achieve substantial net weight loss that more than offsets this effect, particularly when combined with the dietary changes required after the procedure.

Your bariatric team will continue to monitor your health at follow-up appointments, in line with BOMSS postoperative follow-up guidance, and smoking status may be reviewed as part of your ongoing care. If you experience a relapse, contact your GP or NHS Stop Smoking Service promptly — support is available at any stage of your journey.

Frequently Asked Questions